Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
3(25%)
Results Posted
25%(2 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_2
4
33%
Ph phase_1
8
67%

Phase Distribution

8

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
8(66.7%)
Phase 2Efficacy & side effects
4(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(8)
Terminated(1)

Detailed Status

Completed8
Recruiting3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
88.9%
Most Advanced
Phase 2

Trials by Phase

Phase 18 (66.7%)
Phase 24 (33.3%)

Trials by Status

terminated18%
completed867%
recruiting325%

Recent Activity

3 active trials
Showing 5 of 12
recruitingphase_1

Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease

NCT07224490
terminatedphase_1

Recall by Genotype: Neuropeptide Stimulation

NCT05901467
completedphase_2

Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism

NCT04648969
recruitingphase_2

Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea

NCT07224438
completedphase_1

Dampening the Reproductive Axis With Continuous Kisspeptin

NCT05971849
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT07224490Phase 1

Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease

Recruiting
NCT05901467Phase 1

Recall by Genotype: Neuropeptide Stimulation

Terminated
NCT04648969Phase 2

Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism

Completed
NCT07224438Phase 2

Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea

Recruiting
NCT05971849Phase 1

Dampening the Reproductive Axis With Continuous Kisspeptin

Completed
NCT05896293Phase 2

Kisspeptin Administration Subcutaneously to Patients With IHH

Recruiting
NCT05633966Phase 1

Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders

Completed
NCT02956447Phase 2

Administration of Kisspeptin in Patients With Hyperprolactinemia

Completed
NCT01952782Phase 1

Neuropeptides in Human Reproduction

Completed
NCT00914823Phase 1

Kisspeptin Administration in the Adult

Completed
NCT01438034Phase 1

Kisspeptin in the Evaluation of Delayed Puberty

Completed
NCT01438073Phase 1

Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12